NCT05642845 - Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 19, 2022

Primary Completion Date

December 21, 2022

Study Completion Date

June 5, 2023

Conditions

Bioequivalence

Interventions

DRUG

Atorvastatin film-coated tablet 40 mg

Atorvastatin is manufactured by Pharmtechnology LLC, Republic of Belarus. Each tablet contains 40 mg of atorvastatin.

DRUG

Liprimar® film-coated tablet 40 mg

"Liprimar® is manufactured by Pfizer Pharmaceuticals LLC, Puerto Rico, LLC Polysan Scientific and Technological Pharmaceutical Firm; RU holder: Pfizer Inc, USA. Each tablet contains 40 mg of atorvastatin."

Trial Locations (1)

150010

"State Budgetary Healthcare Institution of the Yaroslavl Region Clinical Hospital No. 2", Yaroslavl

All Listed Sponsors

collaborator

ClinPharmInvest, LLC

OTHER

lead

Pharmtechnology LLC

INDUSTRY